AO AKTIS ONCOLOGY, INC. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the AKTIS ONCOLOGY, INC. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.5bn. The latest transaction was reported on 21 July 2026 (Levée d'options). Among the most active insiders: Herrmann Ken. The full history is free.
Analyst consensus: bullish or bearish? Analysts rate AKTIS ONCOLOGY, INC. Strong Buy (bullish), based on 8 analysts. Average price target: US$34.81.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 July 2026
All Executives25 Thresholds0 Prospectus0 Other0
Declarations 25 total
◇ Director · Executives · 20 Jul 2026
1,350 shares @ US$1.91 0.0002% mcap 1.3% of flow Common Stock SEC:0001193125-26-310991:1
◇ Director · Executives · 20 Jul 2026
3,506 shares @ US$0.08 0.0000% mcap 0.1% of flow Common Stock SEC:0001193125-26-310991:0
▼ Director · Executives · 20 Jul 2026
3,506 shares @ US$24.5622 0.0062% mcap 43.1% of flow Common Stock SEC:0001193125-26-310991:2
▼ Director · Executives · 20 Jul 2026
1,350 shares @ US$24.5622 0.0024% mcap 16.6% of flow Common Stock SEC:0001193125-26-310991:3
● Director · Executives · 20 Jul 2026
4,856 shares @ US$24.5623 0.0087% mcap 60.7% of flow Common SEC144:0001950047-26-007234
◇ Director · Executives · 17 Jul 2026
3,065 shares @ US$0.08 0.0000% mcap 0.3% of flow Common Stock SEC:0001193125-26-309115:0
▼ Director · Executives · 17 Jul 2026
3,065 shares @ US$25.2067 0.0056% mcap 99.7% of flow Common Stock SEC:0001193125-26-309115:1
● Director · Executives · 17 Jul 2026
3,065 shares @ US$25.2067 0.0056% mcap 100.0% of flow Common SEC144:0001950047-26-007199
◇ Chief Medical Officer · Executives · 8 Jul 2026
50,000 shares @ US$4.95 15.1% of flow Common Stock SEC:0001193125-26-300162:0
▼ Chief Medical Officer · Executives · 8 Jul 2026
14,800 shares @ US$27.1273 24.5% of flow Common Stock SEC:0001193125-26-300162:1
▼ Chief Medical Officer · Executives · 8 Jul 2026
30,829 shares @ US$27.9521 52.7% of flow Common Stock SEC:0001193125-26-300162:2
▼ Chief Medical Officer · Executives · 8 Jul 2026
4,371 shares @ US$28.7078 7.7% of flow Common Stock SEC:0001193125-26-300162:3
◇ Chief Operating Officer · Executives · 8 Jul 2026
50,000 shares @ US$3.66 11.7% of flow Common Stock SEC:0001193125-26-300163:0
▼ Chief Operating Officer · Executives · 8 Jul 2026
15,800 shares @ US$27.1317 27.3% of flow Common Stock SEC:0001193125-26-300163:1
▼ Chief Operating Officer · Executives · 8 Jul 2026
30,000 shares @ US$27.9379 53.4% of flow Common Stock SEC:0001193125-26-300163:2
▼ Chief Operating Officer · Executives · 8 Jul 2026
4,200 shares @ US$28.7476 7.7% of flow Common Stock SEC:0001193125-26-300163:3
● Officer · Executives · 8 Jul 2026
50,000 shares @ US$27.7512 100.0% of flow Common SEC144:0001950047-26-006960
● Officer · Executives · 8 Jul 2026
50,000 shares @ US$27.774 100.0% of flow Common SEC144:0001950047-26-006961
1,314,262 shares Common Stock SEC:0001231919-26-000057:0
1,314,262 shares Common Stock SEC:0001231919-26-000055:0
● Director · Executives · 12 Jan 2026
597,391 shares Common Stock SEC:0001473930-26-000005:0
● Director · Executives · 12 Jan 2026
2,270,879 shares Common Stock SEC:0000935836-26-000031:0
4,859,370 shares Common Stock SEC:0001193125-26-010617:0
● Director · Executives · 12 Jan 2026
19,631 shares Common Stock SEC:0001193125-26-010575:0
● Director · Executives · 12 Jan 2026
4,859,370 shares Common Stock SEC:0001193125-26-010566:0
关于 AKTIS ONCOLOGY, INC. AKTIS ONCOLOGY, INC. 是一家专注于开发创新癌症治疗方法的公司。它专注于靶向疗法以改善患者预后。